Guanosine monophosphate reductase 1 is a potential therapeutic target for Alzheimer’s disease

Nature·Feb 9

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

research suggests that guanosine monophosphate reductase 1 may be a potential target for treating alzheimer's disease. this enzyme is being considered as a possible focus for therapeutic interventions. its potential as a target for alzheimer's disease treatment is being explored.

Full coverage

The pathway network of aldo-keto reductase 1b10: a new perspective on gene-targeted therapy

Nature·Jun 22

PurFect timing: revisiting purine metabolism for tuberculosis treatment

ScienceDirect.com·Mar 28

Roles of nucleotide metabolism in pancreatic cancer

Frontiers·Sep 26

Potential shared gene signatures and molecular mechanisms between recurrent pregnancy loss and ovarian cancer

Frontiers·Oct 29

Epigenetics-targeted drugs: current paradigms and future challenges | Signal Transduction and Targeted Therapy

Nature·Nov 26

Landscape of targets within nucleoside metabolism for the modification of immune responses

Frontiers·Apr 25

Targeting metabolic reprogramming in glioblastoma as a new strategy to overcome therapy resistance

Frontiers·Feb 25

Nucleotide metabolism: a pan-cancer metabolic dependency

Nature·Mar 27

View original report at Nature ↗

Fetching the latest headlines…